These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

624 related articles for article (PubMed ID: 22290262)

  • 1. Novel delivery strategies for glioblastoma.
    Zhou J; Atsina KB; Himes BT; Strohbehn GW; Saltzman WM
    Cancer J; 2012; 18(1):89-99. PubMed ID: 22290262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanocarriers for the treatment of glioblastoma multiforme: Current state-of-the-art.
    Karim R; Palazzo C; Evrard B; Piel G
    J Control Release; 2016 Apr; 227():23-37. PubMed ID: 26892752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.
    van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE
    Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging of convection enhanced delivery of toxins in humans.
    Mehta AI; Choi BD; Raghavan R; Brady M; Friedman AH; Bigner DD; Pastan I; Sampson JH
    Toxins (Basel); 2011 Mar; 3(3):201-6. PubMed ID: 22069706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug delivery approaches for the treatment of glioblastoma multiforme.
    Fakhoury M
    Artif Cells Nanomed Biotechnol; 2016 Sep; 44(6):1365-73. PubMed ID: 26046399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glioblastoma chemotherapeutic agents used in the clinical setting and in clinical trials: Nanomedicine approaches to improve their efficacy.
    Aparicio-Blanco J; Sanz-Arriazu L; Lorenzoni R; Blanco-Prieto MJ
    Int J Pharm; 2020 May; 581():119283. PubMed ID: 32240807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of KATP channels increases anticancer drug delivery to brain tumors and survival.
    Ningaraj NS; Sankpal UT; Khaitan D; Meister EA; Vats T
    Eur J Pharmacol; 2009 Jan; 602(2-3):188-93. PubMed ID: 19027730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies to improve delivery of anticancer drugs across the blood-brain barrier to treat glioblastoma.
    Oberoi RK; Parrish KE; Sio TT; Mittapalli RK; Elmquist WF; Sarkaria JN
    Neuro Oncol; 2016 Jan; 18(1):27-36. PubMed ID: 26359209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delivering Therapeutics to Glioblastoma: Overcoming Biological Constraints.
    Mathew EN; Berry BC; Yang HW; Carroll RS; Johnson MD
    Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting brain tumors with innovative nanocarriers: bridging the gap through the blood-brain barrier.
    Wadhwa K; Chauhan P; Kumar S; Pahwa R; Verma R; Goyal R; Singh G; Sharma A; Rao N; Kaushik D
    Oncol Res; 2024; 32(5):877-897. PubMed ID: 38686045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting glioblastoma-derived pericytes improves chemotherapeutic outcome.
    Guerra DAP; Paiva AE; Sena IFG; Azevedo PO; Silva WN; Mintz A; Birbrair A
    Angiogenesis; 2018 Nov; 21(4):667-675. PubMed ID: 29761249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent developments in drug delivery strategies for targeting DNA damage response in glioblastoma.
    Morás AM; Henn JG; Steffens Reinhardt L; Lenz G; Moura DJ
    Life Sci; 2021 Dec; 287():120128. PubMed ID: 34774874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effective treatment of glioblastoma requires crossing the blood-brain barrier and targeting tumors including cancer stem cells: The promise of nanomedicine.
    Kim SS; Harford JB; Pirollo KF; Chang EH
    Biochem Biophys Res Commun; 2015 Dec; 468(3):485-9. PubMed ID: 26116770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glioblastoma multiforme: a glance at advanced therapies based on nanotechnology.
    Rezaei V; Rabiee A; Khademi F
    J Chemother; 2020 May; 32(3):107-117. PubMed ID: 31984871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase I trial of carboplatin administered by convection-enhanced delivery to patients with recurrent/progressive glioblastoma multiforme.
    White E; Bienemann A; Taylor H; Hopkins K; Cameron A; Gill S
    Contemp Clin Trials; 2012 Mar; 33(2):320-31. PubMed ID: 22101221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in targeted drug delivery for the treatment of glioblastoma.
    Mao M; Wu Y; He Q
    Nanoscale; 2024 May; 16(18):8689-8707. PubMed ID: 38606460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy Delivery Strategies to the Central Nervous System: neither Optional nor Superfluous.
    Drapeau A; Fortin D
    Curr Cancer Drug Targets; 2015; 15(9):752-68. PubMed ID: 26077730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current status of local therapy in malignant gliomas--a clinical review of three selected approaches.
    Juratli TA; Schackert G; Krex D
    Pharmacol Ther; 2013 Sep; 139(3):341-58. PubMed ID: 23694764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delivery of molecularly targeted therapy to malignant glioma, a disease of the whole brain.
    Agarwal S; Sane R; Oberoi R; Ohlfest JR; Elmquist WF
    Expert Rev Mol Med; 2011 May; 13():e17. PubMed ID: 21676290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overcoming Barriers in Glioblastoma-Advances in Drug Delivery Strategies.
    Ter Linden E; Abels ER; van Solinge TS; Neefjes J; Broekman MLD
    Cells; 2024 Jun; 13(12):. PubMed ID: 38920629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.